Genomic medicine is the back bone of precision medicine. The cancer genetics program is heavily involved in clinical and precision medicine research within HMC and works collaboratively with other institutions in Qatar including Qatar's University, Sidra Medical Centre, Weill Cornell Medical College, and Qatar's Genome National Project on several clinical research projects.
Qatar has a relatively small population, which provides a unique opportunity to strategically coordinate cancer research in a focused and effective manner. We carry out clinical, translational, and basic science genetics research projects with local institutes as well as with international prestigious centres with the mission to further understand and explore the genetic components of familial and inherited cancers in Qatar, its genotype-phenotype correlations and identifying sporadic and founder effects contributing to the disease incidence and prevalence in Qatar through considering inter- and intra-tumor genetic variability, tumor environment, and individual’s lifestyle and morbidities. In addition, to aiming for optimizing precision medicine research to improve cancer treatment,
Our research aims to enhance the understanding of familial cancers and identifying common mutations targets which can guide early and personalized treatment and prevention modalities for patients in addition to their asymptomatic family members thus benefiting from risk reducing strategies and reducing mortality and morbidity relating to hereditary cancers.
